Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:1231-1237
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lai, L.-P.
Right arrow Articles by Lien, W.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lai, L.-P.
Right arrow Articles by Lien, W.-P.

Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban

An insight into the mechanism of atrial electrical remodeling

Ling-Ping Lai, MD* {dagger}, Ming-Jai Su, PhD*, Jiunn-Lee Lin, MD{dagger}, Fang-Yue Lin, MD{ddagger}, Chang-Her Tsai, MD{ddagger}, Yih-Sharng Chen, MD{ddagger}, Shoei K. Stephen Huang, MD, FACC{dagger}, Yung-Zu Tseng, MD{dagger} and Wen-Pin Lien, MD, FACC{dagger}

* Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan
{dagger} Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
{ddagger} Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan



View larger version (100K):

[in a new window]
 
Figure 1 Representative figures of the polymerase chain reaction products after agarose gel electrophoresis. Coamplification of each of the calcium-handling protein genes with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) showed no interference between the primer pairs, and the two deoxyribonucleic acid bands could be well separated by gel electrophoresis (upper band for calcium-handling protein and lower band for GAPDH). The upper panel shows the polymerase chain reaction results from Patient No. 13 and the lower panel from Patient No. 21, and the samples for each calcium-handling gene were right atrial appendage, right atrial free wall, left atrial appendage and left atrial free wall from left to right. Despite a large variation of messenger ribonucleic acid (mRNA) levels of L-type calcium channel and calcium adenosine triphosphatase (Ca2+-ATPase) between patients, the mRNA levels of the genes among the four atrial sampling sites were not significantly different in the same patient. Lane specification: lanes 1 and 22 = molecular weight marker; lanes 2 to 5 = L-type calcium channel; lanes 6 to 9 = Ca2+-ATPase; lanes 10 to 13 = calsequestrin (CQ); lanes 14 to 17 = ryanodine receptor (RYR); lanes 18 to 21 = phospholamban (PLB).

 


View larger version (18K):

[in a new window]
 
Figure 2 The messenger ribonucleic acid (mRNA) levels of L-type calcium channel and of calcium adenosine triphosphatase (Ca2+-ATPase) in patients with different atrial fibrillation (Af) scores. The mRNA levels of both genes were significantly decreased in patients with an atrial fibrillation score of 3. However, the mRNA levels were not significantly different among patients with atrial fibrillation scores of 0, 1 and 2. *p < 0.05 when compared with atrial fibrillation score 0, 1 and 2. Error bars represent standard deviations.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement